Global Non-Invasive Prenatal Screening (NIPS) Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Non-Invasive Prenatal Screening (NIPS) market size was valued at US$ 3788 million in 2025 and is forecast to a readjusted size of US$ 6028 million by 2032 with a CAGR of 6.9% during review period.
Non-Invasive Prenatal Screening (NIPS) is a prenatal testing method that analyzes genetic material from a pregnancy related blood sample to assess the risk of certain chromosomal or genetic conditions in the fetus without posing physical risk to the pregnancy. It is designed as a screening tool rather than a diagnostic test and is used to identify pregnancies that may benefit from further confirmatory testing and specialized clinical management.
The non invasive prenatal screening market has transitioned from a niche offering for high risk pregnancies into a mainstream component of prenatal care, driven by its strong clinical performance, low procedural risk, and growing acceptance among clinicians and expectant parents. Market dynamics are shaped by rapid technological standardization, intensifying competition, and gradual price compression, which together shift differentiation away from basic test availability toward service quality, turnaround time, reporting clarity, and integration with counseling and follow up pathways. While growth remains robust due to expanding geographic adoption and broader clinical indications, the market is increasingly influenced by reimbursement policy, ethical oversight, and evidence based guideline updates, positioning it as a mature but still structurally expanding segment within prenatal diagnostics.
This report is a detailed and comprehensive analysis for global Non-Invasive Prenatal Screening (NIPS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Non-Invasive Prenatal Screening (NIPS) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Non-Invasive Prenatal Screening (NIPS) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Invasive Prenatal Screening (NIPS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Prenatal Screening (NIPS), with revenue, gross margin, and global market share of Non-Invasive Prenatal Screening (NIPS) from 2021 to 2026.
Chapter 3, the Non-Invasive Prenatal Screening (NIPS) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Non-Invasive Prenatal Screening (NIPS) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Prenatal Screening (NIPS).
Chapter 13, to describe Non-Invasive Prenatal Screening (NIPS) research findings and conclusion.
Non-Invasive Prenatal Screening (NIPS) is a prenatal testing method that analyzes genetic material from a pregnancy related blood sample to assess the risk of certain chromosomal or genetic conditions in the fetus without posing physical risk to the pregnancy. It is designed as a screening tool rather than a diagnostic test and is used to identify pregnancies that may benefit from further confirmatory testing and specialized clinical management.
The non invasive prenatal screening market has transitioned from a niche offering for high risk pregnancies into a mainstream component of prenatal care, driven by its strong clinical performance, low procedural risk, and growing acceptance among clinicians and expectant parents. Market dynamics are shaped by rapid technological standardization, intensifying competition, and gradual price compression, which together shift differentiation away from basic test availability toward service quality, turnaround time, reporting clarity, and integration with counseling and follow up pathways. While growth remains robust due to expanding geographic adoption and broader clinical indications, the market is increasingly influenced by reimbursement policy, ethical oversight, and evidence based guideline updates, positioning it as a mature but still structurally expanding segment within prenatal diagnostics.
This report is a detailed and comprehensive analysis for global Non-Invasive Prenatal Screening (NIPS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Non-Invasive Prenatal Screening (NIPS) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Non-Invasive Prenatal Screening (NIPS)
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Non-Invasive Prenatal Screening (NIPS) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Screening in Uncomplicated Pregnancies
- Screening in High-Risk Pregnancies
- Others
- First-trimester Screening
- Second-trimester Screening
- Late-pregnancy Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Invasive Prenatal Screening (NIPS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Prenatal Screening (NIPS), with revenue, gross margin, and global market share of Non-Invasive Prenatal Screening (NIPS) from 2021 to 2026.
Chapter 3, the Non-Invasive Prenatal Screening (NIPS) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Non-Invasive Prenatal Screening (NIPS) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Prenatal Screening (NIPS).
Chapter 13, to describe Non-Invasive Prenatal Screening (NIPS) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Invasive Prenatal Screening (NIPS) by Type
1.3.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type in 2025
1.3.3 Screening in Uncomplicated Pregnancies
1.3.4 Screening in High-Risk Pregnancies
1.3.5 Others
1.4 Classification of Non-Invasive Prenatal Screening (NIPS) by Screening Timing
1.4.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing: 2021 Versus 2025 Versus 2032
1.4.2 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Screening Timing in 2025
1.4.3 First-trimester Screening
1.4.4 Second-trimester Screening
1.4.5 Late-pregnancy Screening
1.5 Classification of Non-Invasive Prenatal Screening (NIPS) by Service Model
1.5.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model: 2021 Versus 2025 Versus 2032
1.5.2 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Service Model in 2025
1.5.3 Public Health Program
1.5.4 Consumer
1.5.5 Others
1.6 Global Non-Invasive Prenatal Screening (NIPS) Market by Application
1.6.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Private Hospitals
1.7 Global Non-Invasive Prenatal Screening (NIPS) Market Size & Forecast
1.8 Global Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast by Region
1.8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region, (2021-2032)
1.8.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.6 South America Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Revvity
2.1.1 Revvity Details
2.1.2 Revvity Major Business
2.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.1.4 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Revvity Recent Developments and Future Plans
2.2 Quest Diagnostics
2.2.1 Quest Diagnostics Details
2.2.2 Quest Diagnostics Major Business
2.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.2.4 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Quest Diagnostics Recent Developments and Future Plans
2.3 MedGenome
2.3.1 MedGenome Details
2.3.2 MedGenome Major Business
2.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.3.4 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 MedGenome Recent Developments and Future Plans
2.4 Mayo Clinic Laboratories
2.4.1 Mayo Clinic Laboratories Details
2.4.2 Mayo Clinic Laboratories Major Business
2.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.4.4 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.5 SYNLAB
2.5.1 SYNLAB Details
2.5.2 SYNLAB Major Business
2.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.5.4 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 SYNLAB Recent Developments and Future Plans
2.6 Veritas Genetics
2.6.1 Veritas Genetics Details
2.6.2 Veritas Genetics Major Business
2.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.6.4 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Veritas Genetics Recent Developments and Future Plans
2.7 GGA
2.7.1 GGA Details
2.7.2 GGA Major Business
2.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.7.4 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 GGA Recent Developments and Future Plans
2.8 Cordlife
2.8.1 Cordlife Details
2.8.2 Cordlife Major Business
2.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.8.4 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Cordlife Recent Developments and Future Plans
2.9 BGI Genomics
2.9.1 BGI Genomics Details
2.9.2 BGI Genomics Major Business
2.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.9.4 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BGI Genomics Recent Developments and Future Plans
2.10 Berry Genomics
2.10.1 Berry Genomics Details
2.10.2 Berry Genomics Major Business
2.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.10.4 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Berry Genomics Recent Developments and Future Plans
2.11 Annaroad
2.11.1 Annaroad Details
2.11.2 Annaroad Major Business
2.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.11.4 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Annaroad Recent Developments and Future Plans
2.12 Genesky
2.12.1 Genesky Details
2.12.2 Genesky Major Business
2.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.12.4 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Genesky Recent Developments and Future Plans
2.13 Weihansi Biomedical Technology
2.13.1 Weihansi Biomedical Technology Details
2.13.2 Weihansi Biomedical Technology Major Business
2.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.13.4 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Non-Invasive Prenatal Screening (NIPS) by Company Revenue
3.2.2 Top 3 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
3.2.3 Top 6 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
3.3 Non-Invasive Prenatal Screening (NIPS) Market: Overall Company Footprint Analysis
3.3.1 Non-Invasive Prenatal Screening (NIPS) Market: Region Footprint
3.3.2 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
3.3.3 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value and Market Share by Type (2021-2026)
4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2026)
5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
6.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2032)
6.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
6.3.1 North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
6.3.2 United States Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
6.3.3 Canada Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
6.3.4 Mexico Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
7.2 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
7.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
7.3.2 Germany Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.3 France Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.5 Russia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.6 Italy Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2032)
8.3.2 China Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.3 Japan Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.4 South Korea Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.5 India Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.7 Australia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
9.2 South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
9.3 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
9.3.1 South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
9.3.2 Brazil Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
9.3.3 Argentina Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
10.3.2 Turkey Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
10.3.4 UAE Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Non-Invasive Prenatal Screening (NIPS) Market Drivers
11.2 Non-Invasive Prenatal Screening (NIPS) Market Restraints
11.3 Non-Invasive Prenatal Screening (NIPS) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Invasive Prenatal Screening (NIPS) Industry Chain
12.2 Non-Invasive Prenatal Screening (NIPS) Upstream Analysis
12.3 Non-Invasive Prenatal Screening (NIPS) Midstream Analysis
12.4 Non-Invasive Prenatal Screening (NIPS) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Invasive Prenatal Screening (NIPS) by Type
1.3.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type in 2025
1.3.3 Screening in Uncomplicated Pregnancies
1.3.4 Screening in High-Risk Pregnancies
1.3.5 Others
1.4 Classification of Non-Invasive Prenatal Screening (NIPS) by Screening Timing
1.4.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing: 2021 Versus 2025 Versus 2032
1.4.2 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Screening Timing in 2025
1.4.3 First-trimester Screening
1.4.4 Second-trimester Screening
1.4.5 Late-pregnancy Screening
1.5 Classification of Non-Invasive Prenatal Screening (NIPS) by Service Model
1.5.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model: 2021 Versus 2025 Versus 2032
1.5.2 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Service Model in 2025
1.5.3 Public Health Program
1.5.4 Consumer
1.5.5 Others
1.6 Global Non-Invasive Prenatal Screening (NIPS) Market by Application
1.6.1 Overview: Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Public Hospitals
1.6.3 Private Hospitals
1.7 Global Non-Invasive Prenatal Screening (NIPS) Market Size & Forecast
1.8 Global Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast by Region
1.8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region, (2021-2032)
1.8.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.6 South America Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Revvity
2.1.1 Revvity Details
2.1.2 Revvity Major Business
2.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.1.4 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Revvity Recent Developments and Future Plans
2.2 Quest Diagnostics
2.2.1 Quest Diagnostics Details
2.2.2 Quest Diagnostics Major Business
2.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.2.4 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Quest Diagnostics Recent Developments and Future Plans
2.3 MedGenome
2.3.1 MedGenome Details
2.3.2 MedGenome Major Business
2.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.3.4 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 MedGenome Recent Developments and Future Plans
2.4 Mayo Clinic Laboratories
2.4.1 Mayo Clinic Laboratories Details
2.4.2 Mayo Clinic Laboratories Major Business
2.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.4.4 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.5 SYNLAB
2.5.1 SYNLAB Details
2.5.2 SYNLAB Major Business
2.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.5.4 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 SYNLAB Recent Developments and Future Plans
2.6 Veritas Genetics
2.6.1 Veritas Genetics Details
2.6.2 Veritas Genetics Major Business
2.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.6.4 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Veritas Genetics Recent Developments and Future Plans
2.7 GGA
2.7.1 GGA Details
2.7.2 GGA Major Business
2.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.7.4 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 GGA Recent Developments and Future Plans
2.8 Cordlife
2.8.1 Cordlife Details
2.8.2 Cordlife Major Business
2.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.8.4 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Cordlife Recent Developments and Future Plans
2.9 BGI Genomics
2.9.1 BGI Genomics Details
2.9.2 BGI Genomics Major Business
2.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.9.4 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BGI Genomics Recent Developments and Future Plans
2.10 Berry Genomics
2.10.1 Berry Genomics Details
2.10.2 Berry Genomics Major Business
2.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.10.4 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Berry Genomics Recent Developments and Future Plans
2.11 Annaroad
2.11.1 Annaroad Details
2.11.2 Annaroad Major Business
2.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.11.4 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Annaroad Recent Developments and Future Plans
2.12 Genesky
2.12.1 Genesky Details
2.12.2 Genesky Major Business
2.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.12.4 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Genesky Recent Developments and Future Plans
2.13 Weihansi Biomedical Technology
2.13.1 Weihansi Biomedical Technology Details
2.13.2 Weihansi Biomedical Technology Major Business
2.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Solutions
2.13.4 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Non-Invasive Prenatal Screening (NIPS) by Company Revenue
3.2.2 Top 3 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
3.2.3 Top 6 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
3.3 Non-Invasive Prenatal Screening (NIPS) Market: Overall Company Footprint Analysis
3.3.1 Non-Invasive Prenatal Screening (NIPS) Market: Region Footprint
3.3.2 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
3.3.3 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value and Market Share by Type (2021-2026)
4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2026)
5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
6.2 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2032)
6.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
6.3.1 North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
6.3.2 United States Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
6.3.3 Canada Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
6.3.4 Mexico Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
7.2 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
7.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
7.3.2 Germany Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.3 France Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.5 Russia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
7.3.6 Italy Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2032)
8.3.2 China Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.3 Japan Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.4 South Korea Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.5 India Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
8.3.7 Australia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
9.2 South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
9.3 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
9.3.1 South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
9.3.2 Brazil Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
9.3.3 Argentina Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2032)
10.3.2 Turkey Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
10.3.4 UAE Non-Invasive Prenatal Screening (NIPS) Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Non-Invasive Prenatal Screening (NIPS) Market Drivers
11.2 Non-Invasive Prenatal Screening (NIPS) Market Restraints
11.3 Non-Invasive Prenatal Screening (NIPS) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-Invasive Prenatal Screening (NIPS) Industry Chain
12.2 Non-Invasive Prenatal Screening (NIPS) Upstream Analysis
12.3 Non-Invasive Prenatal Screening (NIPS) Midstream Analysis
12.4 Non-Invasive Prenatal Screening (NIPS) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 3. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Revvity Company Information, Head Office, and Major Competitors
Table 8. Revvity Major Business
Table 9. Revvity Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 10. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Revvity Recent Developments and Future Plans
Table 12. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 13. Quest Diagnostics Major Business
Table 14. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 15. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Quest Diagnostics Recent Developments and Future Plans
Table 17. MedGenome Company Information, Head Office, and Major Competitors
Table 18. MedGenome Major Business
Table 19. MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 20. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 22. Mayo Clinic Laboratories Major Business
Table 23. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 24. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 26. SYNLAB Company Information, Head Office, and Major Competitors
Table 27. SYNLAB Major Business
Table 28. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 29. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. SYNLAB Recent Developments and Future Plans
Table 31. Veritas Genetics Company Information, Head Office, and Major Competitors
Table 32. Veritas Genetics Major Business
Table 33. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 34. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Veritas Genetics Recent Developments and Future Plans
Table 36. GGA Company Information, Head Office, and Major Competitors
Table 37. GGA Major Business
Table 38. GGA Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 39. GGA Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. GGA Recent Developments and Future Plans
Table 41. Cordlife Company Information, Head Office, and Major Competitors
Table 42. Cordlife Major Business
Table 43. Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 44. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Cordlife Recent Developments and Future Plans
Table 46. BGI Genomics Company Information, Head Office, and Major Competitors
Table 47. BGI Genomics Major Business
Table 48. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 49. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. BGI Genomics Recent Developments and Future Plans
Table 51. Berry Genomics Company Information, Head Office, and Major Competitors
Table 52. Berry Genomics Major Business
Table 53. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 54. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Berry Genomics Recent Developments and Future Plans
Table 56. Annaroad Company Information, Head Office, and Major Competitors
Table 57. Annaroad Major Business
Table 58. Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 59. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Annaroad Recent Developments and Future Plans
Table 61. Genesky Company Information, Head Office, and Major Competitors
Table 62. Genesky Major Business
Table 63. Genesky Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 64. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Genesky Recent Developments and Future Plans
Table 66. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 67. Weihansi Biomedical Technology Major Business
Table 68. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 69. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 71. Global Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million) by Players (2021-2026)
Table 72. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Players (2021-2026)
Table 73. Breakdown of Non-Invasive Prenatal Screening (NIPS) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 74. Market Position of Players in Non-Invasive Prenatal Screening (NIPS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 75. Head Office of Key Non-Invasive Prenatal Screening (NIPS) Players
Table 76. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
Table 77. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
Table 78. Non-Invasive Prenatal Screening (NIPS) New Market Entrants and Barriers to Market Entry
Table 79. Non-Invasive Prenatal Screening (NIPS) Mergers, Acquisition, Agreements, and Collaborations
Table 80. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value (USD Million) by Type (2021-2026)
Table 81. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Share by Type (2021-2026)
Table 82. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Type (2027-2032)
Table 83. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026)
Table 84. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Application (2027-2032)
Table 85. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 86. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 87. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 88. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 89. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 90. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 91. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 92. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 93. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 94. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 95. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 98. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 99. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2027-2032) & (USD Million)
Table 103. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 104. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 105. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 106. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 107. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 108. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 109. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 110. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 111. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 112. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 113. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Global Key Players of Non-Invasive Prenatal Screening (NIPS) Upstream (Raw Materials)
Table 116. Global Non-Invasive Prenatal Screening (NIPS) Typical Customers
Table 1. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 3. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Revvity Company Information, Head Office, and Major Competitors
Table 8. Revvity Major Business
Table 9. Revvity Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 10. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Revvity Recent Developments and Future Plans
Table 12. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 13. Quest Diagnostics Major Business
Table 14. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 15. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Quest Diagnostics Recent Developments and Future Plans
Table 17. MedGenome Company Information, Head Office, and Major Competitors
Table 18. MedGenome Major Business
Table 19. MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 20. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 22. Mayo Clinic Laboratories Major Business
Table 23. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 24. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 26. SYNLAB Company Information, Head Office, and Major Competitors
Table 27. SYNLAB Major Business
Table 28. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 29. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. SYNLAB Recent Developments and Future Plans
Table 31. Veritas Genetics Company Information, Head Office, and Major Competitors
Table 32. Veritas Genetics Major Business
Table 33. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 34. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Veritas Genetics Recent Developments and Future Plans
Table 36. GGA Company Information, Head Office, and Major Competitors
Table 37. GGA Major Business
Table 38. GGA Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 39. GGA Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. GGA Recent Developments and Future Plans
Table 41. Cordlife Company Information, Head Office, and Major Competitors
Table 42. Cordlife Major Business
Table 43. Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 44. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Cordlife Recent Developments and Future Plans
Table 46. BGI Genomics Company Information, Head Office, and Major Competitors
Table 47. BGI Genomics Major Business
Table 48. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 49. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. BGI Genomics Recent Developments and Future Plans
Table 51. Berry Genomics Company Information, Head Office, and Major Competitors
Table 52. Berry Genomics Major Business
Table 53. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 54. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Berry Genomics Recent Developments and Future Plans
Table 56. Annaroad Company Information, Head Office, and Major Competitors
Table 57. Annaroad Major Business
Table 58. Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 59. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Annaroad Recent Developments and Future Plans
Table 61. Genesky Company Information, Head Office, and Major Competitors
Table 62. Genesky Major Business
Table 63. Genesky Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 64. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Genesky Recent Developments and Future Plans
Table 66. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 67. Weihansi Biomedical Technology Major Business
Table 68. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Solutions
Table 69. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 71. Global Non-Invasive Prenatal Screening (NIPS) Revenue (USD Million) by Players (2021-2026)
Table 72. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Players (2021-2026)
Table 73. Breakdown of Non-Invasive Prenatal Screening (NIPS) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 74. Market Position of Players in Non-Invasive Prenatal Screening (NIPS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 75. Head Office of Key Non-Invasive Prenatal Screening (NIPS) Players
Table 76. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
Table 77. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
Table 78. Non-Invasive Prenatal Screening (NIPS) New Market Entrants and Barriers to Market Entry
Table 79. Non-Invasive Prenatal Screening (NIPS) Mergers, Acquisition, Agreements, and Collaborations
Table 80. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value (USD Million) by Type (2021-2026)
Table 81. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Share by Type (2021-2026)
Table 82. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Type (2027-2032)
Table 83. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026)
Table 84. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Application (2027-2032)
Table 85. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 86. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 87. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 88. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 89. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 90. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 91. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 92. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 93. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 94. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 95. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 98. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 99. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2027-2032) & (USD Million)
Table 103. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 104. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 105. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 106. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 107. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 108. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 109. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2021-2026) & (USD Million)
Table 110. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type (2027-2032) & (USD Million)
Table 111. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2021-2026) & (USD Million)
Table 112. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application (2027-2032) & (USD Million)
Table 113. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Global Key Players of Non-Invasive Prenatal Screening (NIPS) Upstream (Raw Materials)
Table 116. Global Non-Invasive Prenatal Screening (NIPS) Typical Customers
LIST OF FIGURES
Figure 1. Non-Invasive Prenatal Screening (NIPS) Picture
Figure 2. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type in 2025
Figure 4. Screening in Uncomplicated Pregnancies
Figure 5. Screening in High-Risk Pregnancies
Figure 6. Others
Figure 7. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Screening Timing in 2025
Figure 9. First-trimester Screening
Figure 10. Second-trimester Screening
Figure 11. Late-pregnancy Screening
Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Service Model in 2025
Figure 14. Public Health Program
Figure 15. Consumer
Figure 16. Others
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application in 2025
Figure 19. Public Hospitals Picture
Figure 20. Private Hospitals Picture
Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Non-Invasive Prenatal Screening (NIPS) Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region in 2025
Figure 26. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Players in 2025
Figure 33. Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Non-Invasive Prenatal Screening (NIPS) by Player Revenue in 2025
Figure 35. Top 3 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
Figure 36. Top 6 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
Figure 37. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Share by Type (2021-2026)
Figure 38. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Type (2027-2032)
Figure 39. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Share by Application (2021-2026)
Figure 40. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Application (2027-2032)
Figure 41. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 51. France Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region (2021-2032)
Figure 58. China Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 61. India Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 75. Non-Invasive Prenatal Screening (NIPS) Market Drivers
Figure 76. Non-Invasive Prenatal Screening (NIPS) Market Restraints
Figure 77. Non-Invasive Prenatal Screening (NIPS) Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Non-Invasive Prenatal Screening (NIPS) Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source
Figure 1. Non-Invasive Prenatal Screening (NIPS) Picture
Figure 2. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type in 2025
Figure 4. Screening in Uncomplicated Pregnancies
Figure 5. Screening in High-Risk Pregnancies
Figure 6. Others
Figure 7. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Screening Timing in 2025
Figure 9. First-trimester Screening
Figure 10. Second-trimester Screening
Figure 11. Late-pregnancy Screening
Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Service Model in 2025
Figure 14. Public Health Program
Figure 15. Consumer
Figure 16. Others
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application in 2025
Figure 19. Public Hospitals Picture
Figure 20. Private Hospitals Picture
Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Market Non-Invasive Prenatal Screening (NIPS) Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 24. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region (2021-2032)
Figure 25. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region in 2025
Figure 26. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 27. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 28. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 29. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 30. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 31. Company Three Recent Developments and Future Plans
Figure 32. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Players in 2025
Figure 33. Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 34. Market Share of Non-Invasive Prenatal Screening (NIPS) by Player Revenue in 2025
Figure 35. Top 3 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
Figure 36. Top 6 Non-Invasive Prenatal Screening (NIPS) Players Market Share in 2025
Figure 37. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Share by Type (2021-2026)
Figure 38. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Type (2027-2032)
Figure 39. Global Non-Invasive Prenatal Screening (NIPS) Consumption Value Share by Application (2021-2026)
Figure 40. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Application (2027-2032)
Figure 41. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 42. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 43. North America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 44. United States Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 48. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 49. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 50. Germany Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 51. France Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 52. United Kingdom Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 53. Russia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 54. Italy Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 56. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 57. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region (2021-2032)
Figure 58. China Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 61. India Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 65. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 66. South America Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 67. Brazil Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 68. Argentina Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 69. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Type (2021-2032)
Figure 70. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Application (2021-2032)
Figure 71. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 73. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 74. UAE Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 75. Non-Invasive Prenatal Screening (NIPS) Market Drivers
Figure 76. Non-Invasive Prenatal Screening (NIPS) Market Restraints
Figure 77. Non-Invasive Prenatal Screening (NIPS) Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Non-Invasive Prenatal Screening (NIPS) Industrial Chain
Figure 80. Methodology
Figure 81. Research Process and Data Source
